SCHEMBL9857372

SCHEMBL9857372

C=CCOC(=O)CC(Cc1ccccc1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 5/20 0.48
NPSR1 Q6W5P4 2/20 0.46
PKM P14618 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MTNR1A P48039 1/20 0.44
MTNR1B P49286 1/20 0.44
CYP3A4 P08684 1/20 0.44
ALDH1A1 P00352 4/20 0.43
MAPT P10636 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
EPHX1 P07099 1/20 0.40
F2 P00734 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MME P08473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5323999 0.84 GABBR2 (0.57) CASP1NPSR1PKMSMN1; SMN2CYP3A4
SCHEMBL28451834 0.82 SLC15A1 (0.55) CASP1NPSR1PKMSMN1; SMN2MTNR1A
SCHEMBL9292329 0.82 CYP3A4 (0.51) CASP1NPSR1PKMSMN1; SMN2CYP3A4
SCHEMBL28812097 0.81 NPSR1 (0.47) CASP1NPSR1PKMSMN1; SMN2CYP3A4
SCHEMBL31555289 0.81 F2 (0.56) MTNR1AMTNR1BALDH1A1MAPTF2
Hydrochloric Acid SCHEMBL14760907 0.80 NPSR1 (0.46) CASP1NPSR1PKMSMN1; SMN2CYP3A4
SCHEMBL1035975 0.79 SMN1; SMN2 (0.49) CASP1NPSR1PKMSMN1; SMN2CYP3A4
SCHEMBL28110882 0.78 CYP2C19 (0.50) CASP1NPSR1PKMSMN1; SMN2CYP3A4
SCHEMBL27579705 0.78 PKM (0.48) NPSR1PKMSMN1; SMN2CYP3A4ALDH1A1
SCHEMBL4941845 0.78 SMN1; SMN2 (0.48) CASP1NPSR1PKMSMN1; SMN2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4996235-A Selectively inhibiting the uptake of serotonin and norepinephrine ELI LILLY AND COMPANY (US) 1991-02-26 US disclosed
EP-0318233-A2 Improvements in or relating to serotonin and norepinephrine uptake inhibitors ELI LILLY AND COMPANY (US) 1989-05-31 EP disclosed